Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Varicella
2021
Americas
Europe
Clear all
Type of publications
NITAG documentation
(136)
Systematic reviews (SYSVAC)
(5)
Topics
Available to download in languages
Regions
Americas
(64)
Europe
(77)
Africa
(17)
South-East Asia
(2)
Western Pacific
(15)
Countries
Argentina
(1)
Belgium
(15)
Bolivia
(2)
Canada
(16)
Chile
(9)
Denmark
(1)
France
(16)
Germany
(8)
Ireland
(7)
Netherlands
(7)
Spain
(1)
Sweden
(2)
United Kingdom
(19)
United States of America
(36)
Diseases
COVID-19
(140)
Varicella
(1)
Ebola
(1)
Hepatitis B
(1)
Human papillomavirus (HPV)
(5)
Influenza
(4)
Meningococcal disease
(1)
Pneumococcal disease
(1)
Rotavirus
(3)
Vaccine topics
Acceptance
(2)
Coverage
(3)
Ethical issues
(3)
Target population
Adolescents
(1)
Adults
(4)
All age groups
(3)
Children
(3)
Healthcare workers
(1)
Older adults
(2)
Parents/caregivers
(1)
Pregnant women
(5)
Risk group
(2)
Publication date
2021
(141)
2024
(3)
2023
(26)
2022
(74)
2020
(80)
2019
(4)
2017
(3)
2016
(2)
2015
(2)
2014
(2)
2013
(3)
2012
(2)
2011
(2)
2010
(9)
2009
(4)
2008
(1)
2007
(4)
2006
(1)
2005
(3)
1993
(1)
1991
(1)
141 results found
2021
∙
NIAC
NIAC Overview of Recommendations regarding booster doses of COVID-19 Vaccine for those aged 60 to 79 years
2021
∙
NIAC
NIAC Recommendations on booster doses of COVID-19 vaccine for healthcare workers, 16-59 years with underlying conditions, and all those 50-59 years
2021
∙
NIAC
NIAC Recommendations on booster doses of COVID-19 vaccine for those aged 16-49 years
2021
∙
NIAC
NIAC Recommendations on COVID-19 vaccination for children aged 5 to 11 Years
2021
∙
NIAC
NIAC UPDATED RECOMMENDATIONS FOR COVID-19 VACCINATION IN PREGNANCY
2021
∙
Conseil Supérieur de la Santé (CSS)
Non-replicating viral vector vaccines and the Belgian COVID-19 vaccination strategy
2021
∙
JCVI
Optimising the COVID-19 vaccination programme for maximum short-term impact
2021
∙
ACIP
Overview of Janssen’s Single-Dose COVID-19 Vaccine, Ad26.COV2.S
2021
∙
Haut Conseil de la santé publique
Potential impact of the circulation of SARS-CoV-2 variants on the COVID - 19 strategy - 9 April, 2021
2021
∙
Conseil Supérieur de la Santé (CSS)
Prioritization of at-risk groups for SARS-CoV-2 Vaccination (Phase 1b)
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register